GCM
AKYA

Ghisallo Capital Management’s Akoya BioSciences AKYA Stock Holding History

Ghisallo Capital Management’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,000
Closed -$209K – 453
2021
Q3 		$209K Sell
15,000
-5,000
-25% -$83.6K 0.01% 434
2021
Q2 		$387K Buy
+20,000
New +$413K 0.01% 382

Other funds holding AKYA

HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Ghisallo Capital Management's AKYA Position: Q4 2021 in Review

Ghisallo Capital Management sold out of Akoya BioSciences (AKYA) in Q4 2021, closing a stake of 15,000 shares — an estimated $209K sold.

Ghisallo Capital Management first reported a position in AKYA in Q2 2021 and held it in 2 quarters. The position peaked at $387K in Q2 2021. 45 funds tracked by Wall St. Rank hold AKYA as of Q4 2021.

  • Ghisallo Capital Management reported no remaining Akoya BioSciences position as of Q4 2021 after selling out during the quarter.
  • Ghisallo Capital Management sold 15,000 Akoya BioSciences shares in Q4 2021, an estimated $209K.
  • Ghisallo Capital Management first reported a position in Akoya BioSciences in Q2 2021 and held it in 2 quarters.
  • Ghisallo Capital Management's Akoya BioSciences position peaked at $387K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Akoya BioSciences as of Q4 2021.

Based on Ghisallo Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.